In clinical settings, we and others have previously shown that the plasma CF6 level increases in various cardiovascular disorders, where a cause–result connection between increased plasma CF6 and decreased PGI2 has been indicated [8, 28–30]. Here, ATP5PF is linked to cardiovascular disorder.